PURPOSE: P-wave parameters including P-wave dispersion (P d) have been examined in general population to predict development of atrial fibrillation (AF). But data on end-stage renal disease (ESRD) population are limited. P index (Pi) and interatrial block (IAB) as novel parameters may more accurately predict AF and have not been previously investigated in ESRD patients. We aimed to evaluate these novel ECG parameters in ESRD patients. METHODS: Eighty-six HD, 47 CAPD, and 43 age- and gender-matched control subjects were enrolled in the study. P-wave duration was measured in all 12-leads of the surface ECG. The standard deviation of the P-wave duration across the 12 ECG leads was accepted as a Pi. P-wave duration above and equal to 110 ms was defined as IAB. All P-wave parameters were evaluated digitally by two observers. RESULTS: Pi was found to be significantly different among the groups in ANOVA. In post hoc analysis, P i was increased in HD group compared with the control group (p = 0.01). Also, P i tended to increase in CAPD group compared with controls (p = 0.06). The effect of ESRD on P i was independent of age, gender, and systolic blood pressure in univariate covariant analysis. The prevalence of IAB was 61, 55, and 32 % in patients with HD, CAPD, and controls, respectively (p = 0.001). P d was significantly higher in HD group compared with healthy controls. However, Pd values of CAPD patients did not show significant difference compared with controls. CONCLUSION: The present study demonstrated that IAB frequency and Pi were increased in patients with ESRD.
PURPOSE: P-wave parameters including P-wave dispersion (P d) have been examined in general population to predict development of atrial fibrillation (AF). But data on end-stage renal disease (ESRD) population are limited. P index (Pi) and interatrial block (IAB) as novel parameters may more accurately predict AF and have not been previously investigated in ESRDpatients. We aimed to evaluate these novel ECG parameters in ESRDpatients. METHODS: Eighty-six HD, 47 CAPD, and 43 age- and gender-matched control subjects were enrolled in the study. P-wave duration was measured in all 12-leads of the surface ECG. The standard deviation of the P-wave duration across the 12 ECG leads was accepted as a Pi. P-wave duration above and equal to 110 ms was defined as IAB. All P-wave parameters were evaluated digitally by two observers. RESULTS: Pi was found to be significantly different among the groups in ANOVA. In post hoc analysis, P i was increased in HD group compared with the control group (p = 0.01). Also, P i tended to increase in CAPD group compared with controls (p = 0.06). The effect of ESRD on P i was independent of age, gender, and systolic blood pressure in univariate covariant analysis. The prevalence of IAB was 61, 55, and 32 % in patients with HD, CAPD, and controls, respectively (p = 0.001). P d was significantly higher in HD group compared with healthy controls. However, Pd values of CAPD patients did not show significant difference compared with controls. CONCLUSION: The present study demonstrated that IAB frequency and Pi were increased in patients with ESRD.
Authors: E Vázquez; C Sánchez-Perales; F Borrego; M J Garcia-Cortés; C Lozano; M Guzmán; J M Gil; M J Borrego; V Pérez Journal: Am Heart J Date: 2000-12 Impact factor: 4.749
Authors: K Aytemir; N Ozer; E Atalar; E Sade; S Aksöyek; K Ovünç; A Oto; F Ozmen; S Kes Journal: Pacing Clin Electrophysiol Date: 2000-07 Impact factor: 1.976
Authors: Eduardo Vázquez; Carmen Sánchez-Perales; Cristóbal Lozano; Ma José García-Cortés; Francisco Borrego; Manuel Guzmán; Pilar Pérez; Carlos Pagola; Ma José Borrego; Vicente Pérez Journal: Am J Cardiol Date: 2003-10-01 Impact factor: 2.778
Authors: Marco V Perez; Frederick E Dewey; Rachel Marcus; Euan A Ashley; Amin A Al-Ahmad; Paul J Wang; Victor F Froelicher Journal: Am Heart J Date: 2009-10 Impact factor: 4.749
Authors: Mehmet Yazici; Kurtulus Ozdemir; Bulent B Altunkeser; Mehmet Kayrak; M Akif Duzenli; M Akif Vatankulu; Ahmet Soylu; Mehmet S Ulgen Journal: Circ J Date: 2007-06 Impact factor: 2.993
Authors: Giuseppe Mansia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A Struijker Boudier; Alberto Zanchetti Journal: Blood Press Date: 2007 Impact factor: 2.835
Authors: Marco Marano; Anna D'Amato; Antoni Bayés de Luna; Adrian Baranchuk Journal: Ann Noninvasive Electrocardiol Date: 2014-12-26 Impact factor: 1.468
Authors: Marco Marano; Anna D'Amato; Giuseppe Tomasino; Francesco Izzo; Marco Capasso; Eugenio Auletta Journal: Int Urol Nephrol Date: 2015-01-21 Impact factor: 2.370